Vinehealth Raises $5.5M in Seed Funding

London healthtech Vinehealth secures $5.5M to personalise cancer care and support — TFN

Vinehealth, a London-based digital health platform for cancer patients, raised $5.5 million in seed funding led by Talis Capital. The round also included participation from previous investors Playfair Capital and Ascension, as well as angel investors. Vinehealth will use the funds to develop its product, expand its team, and enter the US market. Their AI-powered platform provides scalable patient support programs and collects data for clinical decision-making, service delivery, and research.

Vinehealth Secures $5.5 Million Seed Funding to Expand Cancer Patient Support Platform

Vinehealth is a London, UK-based digital health platform founded in 2018 by Rayna Patel and Georgina Kirby. The company uses a combination of behavioral science and AI to provide scalable patient support programs and collect data. Their app allows patients to self-manage medications, side-effects, and symptoms, and submit 'patient-reported outcome' (PRO) data to support clinical decision-making, service delivery, and clinical research. This data can be used by pharmaceutical companies, insurers, and hospitals. Vinehealth adheres to GDPR requirements for data collation and secondary use.

Vinehealth is a London-based digital health platform using AI and behavioral science to provide scalable patient support programs for cancer patients.

4 years ago

Vinehealth Secures $5.5 Million Seed Funding to Expand Cancer Patient Support Platform

ProblemHealthcare

Solution

Covered on